Resultados da pesquisa - ((((drug dosev) OR (drug doseal))) OR (drug dose)) devel ther*

Pesquisas alternativas:
dosev » doses (Expandir a Pesquisa), dosed (Expandir a Pesquisa), dosen (Expandir a Pesquisa), dosv (Expandir a Pesquisa)
doseal » dosear (Expandir a Pesquisa), doseas (Expandir a Pesquisa), coseal (Expandir a Pesquisa), dosal (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
devel » level (Expandir a Pesquisa), devem (Expandir a Pesquisa)
ther* » them* (Expandir a Pesquisa)

1

Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer

Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer

Por Park, Gab-jin, Bae, Soo Hyeon, Park, Wan-Su, Han, Seunghoon, Park, Min-Ho, Shin, Seok-Ho, Shin, Young G, Yim, Dong-Seok
Publicado no Drug Des Devel Ther (2017)

“... interaction at therapeutic doses. This study aimed to compare the magnitude of DDIs at microdoses and regular...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians

Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians

Por Lee, Jieon, Rhee, Su-jin, Lee, SeungHwan, Yu, Kyung-Sang
Publicado no Drug Des Devel Ther (2018)

“... dose or as multiple doses to healthy Caucasians. METHODS: Thirty-six subjects were enrolled...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Predictive performance of gentamicin dosing nomograms

Predictive performance of gentamicin dosing nomograms

Por Lee, Jieon, Yoon, Seonghae, Shin, Donghoon, Han, HyeKyung, An, Hyungmi, Lee, Jongtae, Lim, Kyoung Soo, Yu, Kyung-Sang, Lee, Howard
Publicado em 2014

“... nomograms may be required in patients with IE, particularly for once-daily dosing. Therapeutic drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction

High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction

Por Gavazzoni, Mara, Gorga, Elio, Derosa, Giuseppe, Maffioli, Pamela, Metra, Marco, Raddino, Riccardo
Publicado no Drug Des Devel Ther (2017)

“...BACKGROUND AND AIM: Clinical benefits of early high-dose statin therapy after acute coronary...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

Dose-dependent effects of atorvastatin on myocardial infarction

Dose-dependent effects of atorvastatin on myocardial infarction

Por Barbarash, Olga, Gruzdeva, Olga, Uchasova, Evgenya, Belik, Ekaterina, Dyleva, Yulia, Karetnikova, Victoria
Publicado no Drug Des Devel Ther (2015)

“..., activation of inflammation, thrombogenesis, and formation of insulin resistance. Statin therapy is thought...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date

Por Moitra, Subhabrata, Bhome, Arvind B, Brashier, Bill B
Publicado no Drug Des Devel Ther (2015)

“..., given the rising morbidity and mortality due to this disease. The fixed-dose combination of aclidinium...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study

Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study

Por Kim, Yo Han, Choi, Hee Youn, Noh, Yook-Hwan, Lee, Shi Hyang, Lim, Hyeong-Seok, Kim, Chin, Bae, Kyun-Seop
Publicado no Drug Des Devel Ther (2015)

“... to carvedilol was proportional over the therapeutic dose range of 8–128 mg. The carvedilol SR formulation...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Is increasing the dose of Entecavir effective in partial virological responders?

Is increasing the dose of Entecavir effective in partial virological responders?

Por Erturk, Ayse, Adnan Akdogan, Remzi, Parlak, Emine, Cure, Erkan, Cumhur Cure, Medine, Ozturk, Cinar
Publicado em 2014

“... transaminase (ALT) normalization at the end of 4 years. CONCLUSION: Increasing ETV dose from 0.5 mg to 1 mg...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Analysis of pramipexole dose–response relationships in Parkinson’s disease

Analysis of pramipexole dose–response relationships in Parkinson’s disease

Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)

“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy was underpowered

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy was underpowered

Por Ortiz, Alberto, Sanchez-Niño, Maria Dolores
Publicado no Drug Des Devel Ther (2015)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: the effects of these drugs on bone repair

Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: the effects of these drugs on bone repair

Por Lisowska, Barbara, Kosson, Dariusz, Domaracka, Karolina
Publicado no Drug Des Devel Ther (2018)

“.... Nonsteroidal anti-inflammatory drugs (NSAIDs) play an essential role associated with their analgesic potency...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism

Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism

Por Lee, Sook Joung, Park, Min Kyu, Shin, Dong-Seong, Chun, Min Ho
Publicado no Drug Des Devel Ther (2017)

“... drugs (NSAIDs). We investigated the inhibitory effects on COX-2 after NSAIDs administration using a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection

Por Zhi, Li-Juan, Wang, Li, Chen, Xing-Kai, Zhai, Xiao-Ying, Wen, Li, Dong, Lei, Jacqz-Aigrain, Evelyne, Shi, Zhong-Ren, Zhao, Wei
Publicado no Drug Des Devel Ther (2018)

“... and Drug Administration for the treatment of infections caused by susceptible bacteria in both adults...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Application of physiologically based pharmacokinetic modeling in predicting drug–drug interactions for sarpogrelate hydrochloride in humans

Application of physiologically based pharmacokinetic modeling in predicting drug–drug interactions for sarpogrelate hydrochloride in humans

Por Min, Jee Sun, Kim, Doyun, Park, Jung Bae, Heo, Hyunjin, Bae, Soo Hyeon, Seo, Jae Hong, Oh, Euichaul, Bae, Soo Kyung
Publicado no Drug Des Devel Ther (2016)

“...BACKGROUND: Evaluating the potential risk of metabolic drug–drug interactions (DDIs) is clinically...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Paclitaxel: new uses for an old drug

Paclitaxel: new uses for an old drug

Por Zhang, Dongshan, Yang, Ruhao, Wang, Shixuan, Dong, Zheng
Publicado em 2014

“...Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy

A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy

Por Washington, Samuel L, Shindel, Alan W
Publicado em 2010

“... of once-daily dose of tadalafil by the US Food and Drug Administration for the management of ED...”
Obter o texto integral
Obter o texto integral

Artigo

17

Metal complexes in cancer therapy – an update from drug design perspective

Metal complexes in cancer therapy – an update from drug design perspective

Por Ndagi, Umar, Mhlongo, Ndumiso, Soliman, Mahmoud E
Publicado no Drug Des Devel Ther (2017)

“..., but the lack of clear distinction between the therapeutic and toxic doses was a major challenge...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers

Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers

Por Kim, Yo Han, Choi, Hee Youn, Lim, Hyeong-Seok, Lee, Shi Hyang, Jeon, Hae Sun, Hong, Donghyun, Kim, Seong Su, Choi, Young Kweon, Bae, Kyun-Seop
Publicado no Drug Des Devel Ther (2015)

“.... The aim of this randomized, single-blind, placebo-controlled, single-dose, dose-escalation study...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease

Por Goláň, Lubor, Goker-Alpan, Ozlem, Holida, Myrl, Kantola, Ikka, Klopotowski, Mariusz, Kuusisto, Johanna, Linhart, Aleš, Musial, Jacek, Nicholls, Kathleen, Gonzalez-Rodriguez, Derlis, Sharma, Reena, Vujkovac, Bojan, Chang, Peter, Wijatyk, Anna
Publicado no Drug Des Devel Ther (2015)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia

Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia

Por Dimitropoulos, Konstantinos, Gravas, Stavros
Publicado no Drug Des Devel Ther (2015)

“.... Therefore, it is well understood that LUTS have multifactorial etiology and often occur in clusters...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
5
6
7
8
9
10
11
Seguinte
[28]